Insight Molecular Diagnostics Statistics Share Statistics Insight Molecular Diagnostics has 28.61M
shares outstanding. The number of shares has increased by 113.84%
in one year.
Shares Outstanding 28.61M Shares Change (YoY) 113.84% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 7.78M Failed to Deliver (FTD) Shares 7,711 FTD / Avg. Volume 10.37%
Short Selling Information The latest short interest is 269.13K, so 0.94% of the outstanding
shares have been sold short.
Short Interest 269.13K Short % of Shares Out 0.94% Short % of Float 1.99% Short Ratio (days to cover) 11.74
Valuation Ratios The PE ratio is -0.51 and the forward
PE ratio is -3.37.
Insight Molecular Diagnostics's PEG ratio is
-0.02.
PE Ratio -0.51 Forward PE -3.37 PS Ratio 16.54 Forward PS 24.6 PB Ratio -2.53 P/FCF Ratio -1.47 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Insight Molecular Diagnostics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.62,
with a Debt / Equity ratio of -0.3.
Current Ratio 1.62 Quick Ratio 1.56 Debt / Equity -0.3 Debt / EBITDA -0.06 Debt / FCF -0.17 Interest Coverage -726.68
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $40.89K Profits Per Employee $-1.32M Employee Count 46 Asset Turnover 0.05 Inventory Turnover 2.78
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.11, so Insight Molecular Diagnostics's
price volatility has been higher than the market average.
Beta 1.11 52-Week Price Change n/a 50-Day Moving Average 2.7 200-Day Moving Average 2.76 Relative Strength Index (RSI) 65.48 Average Volume (20 Days) 74,372
Income Statement In the last 12 months, Insight Molecular Diagnostics had revenue of 1.88M
and earned -60.66M
in profits. Earnings per share was -4.66.
Revenue 1.88M Gross Profit 740K Operating Income -61.04M Net Income -60.66M EBITDA -59.02M EBIT -60.58M Earnings Per Share (EPS) -4.66
Full Income Statement Balance Sheet The company has 8.64M in cash and 3.66M in
debt, giving a net cash position of 4.97M.
Cash & Cash Equivalents 8.64M Total Debt 3.66M Net Cash 4.97M Retained Earnings -350.54M Total Assets 50.52M Working Capital 20.19M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -20.71M
and capital expenditures -516K, giving a free cash flow of -21.23M.
Operating Cash Flow -20.71M Capital Expenditures -516K Free Cash Flow -21.23M FCF Per Share -1.62
Full Cash Flow Statement Margins Gross margin is 39.34%, with operating and profit margins of -3245.14% and -3225.04%.
Gross Margin 39.34% Operating Margin -3245.14% Pretax Margin -3225.04% Profit Margin -3225.04% EBITDA Margin -3137.43% EBIT Margin -3245.14% FCF Margin -1128.6%
Dividends & Yields IMDX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IMDX is $4.25,
which is 38% higher than the current price. The consensus rating is "Buy".
Price Target $4.25 Price Target Difference 38% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 25, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Jul 25, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -12.92 Piotroski F-Score 5
